PDRN Moves From Korean Clinics to Daily Skincare as U.S. Demand Accelerates

As PDRN transitions from clinical injectables to consumer skincare in 2026, Korean Boba Capsule Cream combining PDRN, Vitamin C, and collagen is now on Amazon.

LOS ANGELES, CA, UNITED STATES, May 20, 2026 /EINPresswire.com/ — For years, PDRN — polydeoxyribonucleotide, a DNA fragment derived from salmon — was an ingredient reserved for dermatology clinics in South Korea, administered through injectables and microneedling treatments to support skin regeneration, collagen synthesis, and tissue repair. In 2026, that is changing. A convergence of K-beauty innovation, consumer demand for science-backed skincare, and accessible formulation technology has moved PDRN from the clinic into the daily skincare routine.

According to industry data, PDRN-based skincare products are growing at a 14.1% compound annual growth rate — more than double the rate of traditional cosmetics. Vogue identified PDRN and exosomes as the dominant K-beauty trend for 2026, noting that these ingredients “gained popularity in 2025, and experts anticipate this trend will continue to flourish in 2026 as these ingredients transition from clinical to consumer formats” (Source: Financial Content / MarketersMEdia – financialcontent.com/article/marketersmedia-2026-2-5-seoulceuticals-launches-industrys-first-pdrn-vitamin-c-serum-as-bio-regenerative-actives-dominate-2026-k-beauty).

Beauty Independent confirmed in January 2026 that “PDRN has gone mainstream,” naming it among the breakout ingredients defining skincare’s direction this year (Source: Beauty Independent – beautyindependent.com/top-skincare-trends-2026-those-losing-sizzle).

A PDRN Capsule Cream combining Salmon DNA PDRN, Vitamin C, Niacinamide, and Collagen Jelly is now available on Amazon, offering consumers access to this clinic-grade ingredient in an everyday moisturizer format.

ABOUT PDRN

PDRN works by activating the A2A adenosine receptor, which stimulates fibroblast activity and promotes collagen synthesis, wound healing, and tissue regeneration. Clinical studies have demonstrated PDRN increases dermal density by 8.67% and skin brightness by 4.88% within 28 days. Multiple peer-reviewed studies have demonstrated its ability to improve skin elasticity and reduce visible signs of aging. Originally developed for regenerative medicine applications, its crossover into topical skincare — particularly in South Korea — represents one of the more significant formulation developments in the beauty industry in recent years (Source: Korean Skincare Coach – koreanskincarecoach.com/blog/the-rise-of-pdrn-in-korean-skincare-benefits-uses-and-top-products).

ABOUT THE PRODUCT

The realori PDRN Capsule Cream is a pink jelly-gel moisturizer formulated with four key actives: PDRN with Salmon DNA to support skin regeneration and elasticity; Vitamin C for antioxidant protection and brightening; Niacinamide to address uneven tone and texture; and Collagen Jelly capsules for hydration and firmness. The boba-capsule texture is designed for fast absorption without clogging pores, making it suitable for oily, dry, and combination skin types. The formula is free of harsh alcohols, common allergens, fragrances, parabens, and sulfates, and is formulated for both day and night use.

WHY SUMMER

Summer UV exposure is now documented as the second-largest cause of skin damage after bleaching, with repeated UV exposure accelerating collagen degradation and uneven pigmentation — the precise concerns PDRN and Vitamin C are clinically studied to address. Dermatologists note that antioxidant and regenerative topicals applied consistently over four to eight weeks produce measurable improvement in skin texture, tone, and barrier resilience — making summer an appropriate time to begin a PDRN-based routine ahead of fall, when skin undergoes its natural repair cycle.

The PDRN Capsule Cream is available now on Amazon.

Myah Taylor
REALORI Skincare
email us here

Legal Disclaimer:

EIN Presswire provides this news content “as is” without warranty of any kind. We do not accept any responsibility or liability
for the accuracy, content, images, videos, licenses, completeness, legality, or reliability of the information contained in this
article. If you have any complaints or copyright issues related to this article, kindly contact the author above.

Media gallery

Information contained on this page is provided by an independent third-party content provider. XPRMedia and this Site make no warranties or representations in connection therewith. If you are affiliated with this page and would like it removed please contact pressreleases@xpr.media